MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities ...

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...

Genetic methylation tests have made their way from specialized research facilities to home convenience, allowing individuals to delve into the details of their DNA from the comfort of their homes.

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns for affordable early detection.

A noninvasive urinary DNA methylation test demonstrated high sensitivity for detecting high-grade or invasive bladder cancer. A urinary DNA methylation test displayed superior sensitivity for ...

Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis. Findings indicate that ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, ...

Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers and other diseases from a single, low-cost sample. The study, which ...